Natera Partners With Susan G. Komen to Advance Breast Cancer Awareness
Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...
personalized medicine
Advertisement
NTx Bio Advances Personalized Cancer Vaccine Manufacturing
Rio Rancho, New Mexico, August 19, 2026 NTx Bio is advancing the manufacturing infrastructure supporting personalized cancer vaccines through...
10x Genomics, CHUV Advance Precision Cancer Diagnostics
PLEASANTON, Calif., July 29, 2026 10x Genomics has entered a multi-year research collaboration with Lausanne University Hospital (CHUV) to...
Smith+Nephew Sets New Standard in Sports Medicine AI
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Castle Biosciences Wins NY Approval for AdvanceAD-Tx Test
FRIENDSWOOD, Texas, July 14, 2026 Castle Biosciences, Inc. has announced that its AdvanceAD-Tx™ test has received assay approval from...
Advertisements
PreludeDx Expands DCIS Education Through New Collaboration
LAGUNA HILLS, Calif., July 7, 2026 PreludeDx™, a leader in precision diagnostics for early-stage breast cancer, has announced a...
Alcon and RxSight Partner on Adjustable PCIOL Technology
ALISO VIEJO, Calif., July 6, 2026 Alcon and RxSight, Inc. have announced a strategic collaboration to jointly develop adjustable...
Allarity Therapeutics Secures U.S. Patent for DRP® Platform
TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...
Delphi Diagnostics Validates EAI for Paclitaxel Benefit
HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...
Genprex Strengthens REQORSA Cancer Gene Therapy Patent
AUSTIN, Texas, June 22, 2026 Genprex, Inc. has announced a significant intellectual property milestone after receiving a Notice of...
Advertisement
